Dermata Therapeutics Inc. Insider Trading
DRMA
Insiders bought 1K and sold $13 on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director Kathleen D. Scott sold $13 on Jun 16, 92% of their stake, outside a plan.
Get an email when DRMA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16 | Kathleen D. Scott Director | SoldNo plan | 11 | $1.19 | $13 | 92% | Form 4 |
| Feb 17 | Munera Maria E Bedoya-Toro SVP, Regulatory Affairs | Bought | 1,000 | $1.27 | 1K | 2174% | Form 4 |
- Jun 16No planKathleen D. ScottDirector · sold 11 at $1.19$1392% of stake
- Feb 17Munera Maria E Bedoya-ToroSVP, Regulatory Affairs · bought 1,000 at $1.271K2174% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with DRMA
Spot a number that looks wrong? Check it in DRMA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DRMA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.